$KYMR
Kymera Therapeutics, Inc.

2024 Q1 Form 10-K Financial Statement

#000095017024018414 Filed on February 22, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $10.29M $47.89M $78.59M
YoY Change 8.67% 196.7% 67.84%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $14.37M $14.23M $55.04M
YoY Change 14.4% 22.27% 25.57%
% of Gross Profit
Research & Development $48.82M $52.97M $189.1M
YoY Change 15.61% 22.81% 15.12%
% of Gross Profit
Depreciation & Amortization $1.461M $865.0K $3.565M
YoY Change 66.21% 5.75% 19.75%
% of Gross Profit
Operating Expenses $68.12M $67.20M $244.1M
YoY Change 24.32% 22.69% 17.32%
Operating Profit -$57.83M -$165.5M
YoY Change 27.59% 2.65%
Interest Expense $9.274M $4.944M $18.57M
YoY Change 110.87% 31.31% 187.97%
% of Operating Profit
Other Income/Expense, Net $9.274M $18.57M
YoY Change 110.87% 187.97%
Pretax Income -$48.56M -$14.37M -$147.0M
YoY Change 18.64% -58.79% -5.07%
Income Tax
% Of Pretax Income
Net Earnings -$48.56M -$14.37M -$147.0M
YoY Change 18.64% -58.79% -5.07%
Net Earnings / Revenue -472.02% -30.01% -186.99%
Basic Earnings Per Share -$0.69 -$2.52
Diluted Earnings Per Share -$0.69 -$0.25 -$2.52
COMMON SHARES
Basic Shares Outstanding 61.11M 55.49M 58.37M
Diluted Shares Outstanding 70.77M 58.37M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $520.5M $374.9M $374.9M
YoY Change 31.16% -7.93% -7.93%
Cash & Equivalents $93.51M $110.0M $110.0M
Short-Term Investments $427.0M $264.9M $264.9M
Other Short-Term Assets $14.68M $11.67M $11.67M
YoY Change 29.3% 20.19% 20.19%
Inventory
Prepaid Expenses
Receivables $0.00 $15.00M $18.76M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $537.3M $405.3M $405.3M
YoY Change 30.54% -3.36% -3.36%
LONG-TERM ASSETS
Property, Plant & Equipment $49.34M $48.13M $101.1M
YoY Change 183.02% 260.99% 354.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $224.4M $61.43M $61.43M
YoY Change 88.54% -59.67% -59.67%
Other Assets $2.118M $2.118M $7.929M
YoY Change -32.87% -29.8% -13.32%
Total Long-Term Assets $331.0M $170.4M $170.4M
YoY Change 63.57% -7.23% -7.23%
TOTAL ASSETS
Total Short-Term Assets $537.3M $405.3M $405.3M
Total Long-Term Assets $331.0M $170.4M $170.4M
Total Assets $868.3M $575.8M $575.8M
YoY Change 41.43% -4.54% -4.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.812M $7.075M $7.075M
YoY Change 5.07% 63.21% 63.21%
Accrued Expenses $16.00M $33.86M $35.25M
YoY Change -13.54% 23.13% 18.96%
Deferred Revenue $22.61M $37.88M
YoY Change -29.88% 7.44%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.133M $1.277M $1.277M
YoY Change -15.38% -9.3% -9.3%
Total Short-Term Liabilities $56.14M $85.69M $85.69M
YoY Change -9.36% 20.11% 20.11%
LONG-TERM LIABILITIES
Long-Term Debt $1.156M $1.301M $1.301M
YoY Change 16.89% 4.41% 4.41%
Other Long-Term Liabilities $99.76M $0.00 $93.80M
YoY Change 41991.14% -100.0% 132.2%
Total Long-Term Liabilities $100.9M $0.00 $95.10M
YoY Change 42478.9% -100.0% 128.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $56.14M $85.69M $85.69M
Total Long-Term Liabilities $100.9M $0.00 $95.10M
Total Liabilities $157.0M $180.8M $180.8M
YoY Change 3.39% 60.01% 60.01%
SHAREHOLDERS EQUITY
Retained Earnings -$579.3M -$530.8M
YoY Change 36.4% 38.3%
Common Stock $1.292B $926.3M
YoY Change 45.24% 5.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $711.2M $395.0M $395.0M
YoY Change
Total Liabilities & Shareholders Equity $868.3M $575.8M $575.8M
YoY Change 41.43% -4.54% -4.54%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$48.56M -$14.37M -$147.0M
YoY Change 18.64% -58.79% -5.07%
Depreciation, Depletion And Amortization $1.461M $865.0K $3.565M
YoY Change 66.21% 5.75% 19.75%
Cash From Operating Activities -$39.59M $8.074M -$102.8M
YoY Change -9.95% -120.42% -32.83%
INVESTING ACTIVITIES
Capital Expenditures $7.402M $11.58M $34.48M
YoY Change 84.63% 3004.56% 1115.8%
Acquisitions
YoY Change
Other Investing Activities -$323.2M $30.57M $174.4M
YoY Change -1230.36% -162.01% 646.59%
Cash From Investing Activities -$330.6M $18.99M $139.9M
YoY Change -1444.81% -138.23% 581.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 353.8M 1.892M 4.192M
YoY Change 30422.52% -3.12% -97.26%
NET CHANGE
Cash From Operating Activities -39.59M 8.074M -102.8M
Cash From Investing Activities -330.6M 18.99M 139.9M
Cash From Financing Activities 353.8M 1.892M 4.192M
Net Change In Cash -16.44M 28.95M 41.25M
YoY Change -9.78% -133.18% 101.89%
FREE CASH FLOW
Cash From Operating Activities -$39.59M $8.074M -$102.8M
Capital Expenditures $7.402M $11.58M $34.48M
Free Cash Flow -$46.99M -$3.506M -$137.3M
YoY Change -2.05% -91.22% -11.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2020Q4 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2019Q4 kymr Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001815442
CY2019Q4 kymr Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019Q4 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2019Q4 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2020Q4 kymr Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2020Q4 kymr Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q4 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://www.kymeratx.com/20231231#CollaborationRevenuesFromRelatedPartyMember
CY2022 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://www.kymeratx.com/20231231#CollaborationRevenuesFromRelatedPartyMember
CY2021 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://www.kymeratx.com/20231231#CollaborationRevenuesFromRelatedPartyMember
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-39460
CY2023 dei Entity Registrant Name
EntityRegistrantName
KYMERA THERAPEUTICS, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-2992166
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
200 Arsenal Yards Blvd.
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 230
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
CY2023 dei City Area Code
CityAreaCode
857
CY2023 dei Local Phone Number
LocalPhoneNumber
285-5300
CY2023 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2023 dei Trading Symbol
TradingSymbol
KYMR
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.0001
CY2023Q2 dei Entity Public Float
EntityPublicFloat
1012800000
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61111678
CY2023 dei Auditor Firm
AuditorFirmId
42
CY2023 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2023 dei Auditor Location
AuditorLocation
Boston, Massachusetts
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
109966000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68395000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
264915000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
338771000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15000000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
3762000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2537000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11674000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9713000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
405317000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
419416000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
61434000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
152328000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48134000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13334000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
52945000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8909000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2118000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3017000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
5811000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
6130000
CY2023Q4 us-gaap Assets
Assets
575759000
CY2022Q4 us-gaap Assets
Assets
603134000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7075000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4335000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33864000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27502000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
37883000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
35260000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5068000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2535000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1277000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1408000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
524000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
303000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
85691000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
71343000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
16768000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
28000000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
77028000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12146000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1301000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1246000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
248000
CY2023Q4 us-gaap Liabilities
Liabilities
180788000
CY2022Q4 us-gaap Liabilities
Liabilities
112983000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55585305
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55039380
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
6000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
6000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
926269000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
878884000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-530752000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-383790000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-552000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4949000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
394971000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
490151000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
575759000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
603134000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78592000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46826000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
72832000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
189081000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
164248000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
137017000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
55041000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43834000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36345000
CY2023 us-gaap Operating Expenses
OperatingExpenses
244122000
CY2022 us-gaap Operating Expenses
OperatingExpenses
208082000
CY2021 us-gaap Operating Expenses
OperatingExpenses
173362000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-165530000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-161256000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-100530000
CY2023 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
18764000
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
6624000
CY2021 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
488000
CY2023 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
196000
CY2022 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
176000
CY2021 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
175000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18568000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6448000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
313000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-146962000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-154808000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-100217000
CY2023 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
4397000
CY2022 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-4289000
CY2021 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-532000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-142565000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-159097000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-100749000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-146962000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-154808000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-100217000
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-146962000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-154808000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-100217000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.52
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.52
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.87
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.87
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.09
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.09
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58365499
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58365499
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53933229
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53933229
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47989023
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47989023
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
283888000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7633000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
788000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24972000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-532000
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
16207000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-100217000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
459638000
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
174000
CY2022 kymr Issuance Of Common Stock At Private Placement Net Of Issuance Cost
IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost
149826000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3154000
CY2021 kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-419000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1150000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35480000
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4289000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-154808000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
490151000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2860000
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1407000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
43118000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
4397000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-146962000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
394971000
CY2023 us-gaap Profit Loss
ProfitLoss
-146962000
CY2022 us-gaap Profit Loss
ProfitLoss
-154808000
CY2021 us-gaap Profit Loss
ProfitLoss
-100217000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
43118000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
35480000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
24972000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3565000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2977000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2397000
CY2023 kymr Premiums And Discounts On Available For Sale Marketable Securities
PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
-5229000
CY2022 kymr Premiums And Discounts On Available For Sale Marketable Securities
PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
889000
CY2021 kymr Premiums And Discounts On Available For Sale Marketable Securities
PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
5807000
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-18000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1961000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
992000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4016000
CY2023 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
15000000
CY2022 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
0
CY2021 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-577000
CY2023 kymr Increase Decrease In Contract With Customer Asset Related Parties
IncreaseDecreaseInContractWithCustomerAssetRelatedParties
1226000
CY2022 kymr Increase Decrease In Contract With Customer Asset Related Parties
IncreaseDecreaseInContractWithCustomerAssetRelatedParties
2401000
CY2021 kymr Increase Decrease In Contract With Customer Asset Related Parties
IncreaseDecreaseInContractWithCustomerAssetRelatedParties
-721000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2038000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
253000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
54000
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3180000
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4519000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
12599000
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-8609000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-37774000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-69356000
CY2023 kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-4797000
CY2022 kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-517000
CY2023 kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
18582000
CY2022 kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1004000
CY2021 kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1015000
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-909000
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
998000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1992000
CY2023 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-28000
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
257000
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
86000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-102826000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-153085000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-128946000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34480000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2836000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1597000
CY2023 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
189151000
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
445972000
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
456404000
CY2023 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
363517000
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
469327000
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
358166000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
139886000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
20519000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-99835000
CY2023 kymr Issuance Of Common Stock And Accompanying Pre Funded Warrants At Private Placement Net Of Issuance Costs
IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts
0
CY2022 kymr Issuance Of Common Stock And Accompanying Pre Funded Warrants At Private Placement Net Of Issuance Costs
IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts
149825000
CY2021 kymr Issuance Of Common Stock And Accompanying Pre Funded Warrants At Private Placement Net Of Issuance Costs
IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts
0
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2860000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3154000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7632000
CY2023 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1408000
CY2022 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1150000
CY2021 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
788000
CY2023 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
0
CY2022 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
0
CY2021 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
397000
CY2023 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
76000
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1130000
CY2021 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
849000
CY2023 kymr Proceeds From Follow On Offering Net Of Underwriting Discounts And Offering Costs
ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts
0
CY2022 kymr Proceeds From Follow On Offering Net Of Underwriting Discounts And Offering Costs
ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts
0
CY2021 kymr Proceeds From Follow On Offering Net Of Underwriting Discounts And Offering Costs
ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts
240760000
CY2023 kymr Proceeds From Concurrent Private Placement
ProceedsFromConcurrentPrivatePlacement
0
CY2022 kymr Proceeds From Concurrent Private Placement
ProceedsFromConcurrentPrivatePlacement
0
CY2021 kymr Proceeds From Concurrent Private Placement
ProceedsFromConcurrentPrivatePlacement
2346000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4192000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
152999000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
250280000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
41252000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20433000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
21499000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
74525000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54092000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32593000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
115777000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
74525000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54092000
CY2023 kymr Reduction Of Right Of Use Asset And Liability Due To Lease Modification
ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification
48833000
CY2022 kymr Reduction Of Right Of Use Asset And Liability Due To Lease Modification
ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification
0
CY2021 kymr Reduction Of Right Of Use Asset And Liability Due To Lease Modification
ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification
0
CY2023 us-gaap Interest Paid Net
InterestPaidNet
162000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
179000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
158000
CY2023 kymr Purchases Of Property And Equipment Through Finance And Lease Liabilities
PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities
0
CY2022 kymr Purchases Of Property And Equipment Through Finance And Lease Liabilities
PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities
1506000
CY2021 kymr Purchases Of Property And Equipment Through Finance And Lease Liabilities
PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities
1918000
CY2023 kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
4016000
CY2022 kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
87000
CY2021 kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
42000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
109966000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68395000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47976000
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
5811000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
6130000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
6116000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
115777000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
74525000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54092000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-530800000
CY2023Q4 us-gaap Investments And Cash
InvestmentsAndCash
436300000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingencies at the date of the financial statements and the reported amounts of expenses during the reporting period. Management’s estimates and judgments are derived and continually evaluated based on available information, historical experience and various other assumptions that are believed to be reasonable under the circumstances. Because the use of estimates is inherent in the financial reporting process, actual results could differ from those estimates. In recording transactions and balances resulting from business operations, management makes estimates based on the best information available at the time the estimate is made. Significant estimates relied upon in preparing these financial statements include revenue recognized under our collaboration agreement with Sanofi and Vertex, accrual for research and development expenses, and equity-based compensation expense. As better information becomes available or actual amounts are determinable, the recorded estimates are revised. Consequently, operating results can be affected by revisions to prior estimates.</span></p>
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P1Y
CY2023 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0
CY2022Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0
CY2021 us-gaap Depreciation
Depreciation
2400000
CY2023 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1500000
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1200000
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
900000
CY2023Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.082
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
326907000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
166000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
724000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
326349000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
496044000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
53000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4998000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
491099000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
109
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
229700000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
149
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
330900000
CY2023 kymr Debt Securities Available For Sale Decline In Market Value For Unrealized Loss Position Number Of Securities
DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities
16
CY2023Q4 kymr Debt Securities Available For Sale Continuous Unrealized Loss Position Greater Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months
36600000
CY2022 kymr Debt Securities Available For Sale Decline In Market Value For Unrealized Loss Position Number Of Securities
DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities
36
CY2022Q4 kymr Debt Securities Available For Sale Continuous Unrealized Loss Position Greater Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months
115000000
CY2023 kymr Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
124
CY2023Q4 kymr Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months
FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
264900000
CY2023 kymr Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
27
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
61400000
CY2022 kymr Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
118
CY2022Q4 kymr Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months
FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
338800000
CY2022 kymr Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
81
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
152300000
CY2023Q4 kymr Available For Sale Securities Credit Losses
AvailableForSaleSecuritiesCreditLosses
0
CY2022Q4 kymr Available For Sale Securities Credit Losses
AvailableForSaleSecuritiesCreditLosses
0
CY2023 kymr Cost Reimbursement Payment Received
CostReimbursementPaymentReceived
13800000
CY2022 kymr Cost Reimbursement Payment Received
CostReimbursementPaymentReceived
6700000
CY2023Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
3800000
CY2022Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2500000
CY2023 kymr Remaining Research Term Of Collaboration
RemainingResearchTermOfCollaboration
P3Y
CY2022Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
2537000
CY2023 kymr Contract With Customer Asset Net Additions
ContractWithCustomerAssetNetAdditions
83739000
CY2023 kymr Contract With Customer Asset Net Deductions
ContractWithCustomerAssetNetDeductions
-67514000
CY2023Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
18762000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
63260000
CY2023 kymr Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
69983000
CY2023 kymr Contract With Customer Liability Deductions
ContractWithCustomerLiabilityDeductions
-78592000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
54651000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58574000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20227000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10440000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6893000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48134000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13334000
CY2023 us-gaap Depreciation
Depreciation
3600000
CY2022 us-gaap Depreciation
Depreciation
3000000
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.085
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
9919000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
2095000
CY2023 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1483000
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1184000
CY2023 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
181000
CY2022 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
179000
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
949000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
1192000
CY2023 us-gaap Lease Cost
LeaseCost
12532000
CY2022 us-gaap Lease Cost
LeaseCost
4650000
CY2023 kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
2659000
CY2022 kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
2581000
CY2023 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1363000
CY2022 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1130000
CY2023 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
181000
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
179000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y4M24D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y3M18D
CY2023Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M24D
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.088
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.105
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5505000
CY2023Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
1318000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
12074000
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
882000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12436000
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
533000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
12809000
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
100000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
13193000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
74424000
CY2023Q4 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
0
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
130441000
CY2023Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
2833000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
48345000
CY2023Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
255000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
82096000
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
2578000
CY2023Q4 kymr Undiscounted Future Lease Payments
UndiscountedFutureLeasePayments
4000000
CY2023Q4 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
15099000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q4 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
16975000
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
11227000
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
8149000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3854000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1971000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3684000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
407000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33864000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27502000
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M13D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M9D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M13D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.62
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.62
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.66
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.041
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.021
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.018
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.051
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.286
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.272
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
43118000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
35480000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24972000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.068
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.064
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.106
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.015
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.001
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.096
CY2023 kymr Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0
CY2022 kymr Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0
CY2021 kymr Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.046
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.015
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.077
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.023
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.438
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
33708000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
32320000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
10194000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
8835000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
25975000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
17581000
CY2023Q4 kymr Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
22443000
CY2022Q4 kymr Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
4011000
CY2023Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
9807000
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
16315000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
13636000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
10350000
CY2023Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
68340000
CY2022Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
36435000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
184103000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
125847000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
162375000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
120096000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
21728000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5751000
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
1884000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
2187000
CY2023Q4 kymr Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
19844000
CY2022Q4 kymr Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
3564000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2023 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
42000000
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
151000000
CY2023 kymr Federal Net Operating Loss Carryovers Not Subject To Expiration
FederalNetOperatingLossCarryoversNotSubjectToExpiration
2036000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2022 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-146962000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-154808000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-100217000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58365499
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58365499
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53933229
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53933229
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47989023
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47989023
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.52
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.52
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.87
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.87
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.09
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.09
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8706304
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7039132
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6276927

Files In Submission

Name View Source Status
0000950170-24-018414-index-headers.html Edgar Link pending
0000950170-24-018414-index.html Edgar Link pending
0000950170-24-018414.txt Edgar Link pending
0000950170-24-018414-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img10132136_0.jpg Edgar Link pending
img10132136_1.jpg Edgar Link pending
img10132136_10.jpg Edgar Link pending
img10132136_11.jpg Edgar Link pending
img10132136_12.jpg Edgar Link pending
img10132136_13.jpg Edgar Link pending
img10132136_14.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
img10132136_2.jpg Edgar Link pending
img10132136_3.jpg Edgar Link pending
img10132136_4.jpg Edgar Link pending
img10132136_5.jpg Edgar Link pending
img10132136_6.jpg Edgar Link pending
img10132136_7.jpg Edgar Link pending
img10132136_8.jpg Edgar Link pending
img10132136_9.jpg Edgar Link pending
img255116984_0.jpg Edgar Link pending
img255116984_1.jpg Edgar Link pending
img255116984_10.jpg Edgar Link pending
img255116984_11.jpg Edgar Link pending
img255116984_12.jpg Edgar Link pending
img255116984_13.jpg Edgar Link pending
img255116984_14.jpg Edgar Link pending
img255116984_15.jpg Edgar Link pending
img255116984_16.jpg Edgar Link pending
img255116984_17.jpg Edgar Link pending
img255116984_18.jpg Edgar Link pending
img255116984_19.jpg Edgar Link pending
img255116984_2.jpg Edgar Link pending
img255116984_20.jpg Edgar Link pending
img255116984_21.jpg Edgar Link pending
img255116984_22.jpg Edgar Link pending
img255116984_23.jpg Edgar Link pending
img255116984_24.jpg Edgar Link pending
img255116984_25.jpg Edgar Link pending
img255116984_26.jpg Edgar Link pending
img255116984_27.jpg Edgar Link pending
img255116984_28.jpg Edgar Link pending
img255116984_29.jpg Edgar Link pending
img255116984_3.jpg Edgar Link pending
img255116984_30.jpg Edgar Link pending
img255116984_31.jpg Edgar Link pending
img255116984_32.jpg Edgar Link pending
img255116984_33.jpg Edgar Link pending
img255116984_34.jpg Edgar Link pending
img255116984_35.jpg Edgar Link pending
img255116984_36.jpg Edgar Link pending
img255116984_37.jpg Edgar Link pending
img255116984_38.jpg Edgar Link pending
img255116984_39.jpg Edgar Link pending
img255116984_4.jpg Edgar Link pending
img255116984_40.jpg Edgar Link pending
img255116984_41.jpg Edgar Link pending
img255116984_42.jpg Edgar Link pending
img255116984_43.jpg Edgar Link pending
img255116984_44.jpg Edgar Link pending
img255116984_45.jpg Edgar Link pending
img255116984_46.jpg Edgar Link pending
img255116984_47.jpg Edgar Link pending
img255116984_48.jpg Edgar Link pending
img255116984_49.jpg Edgar Link pending
img255116984_5.jpg Edgar Link pending
img255116984_50.jpg Edgar Link pending
img255116984_51.jpg Edgar Link pending
img255116984_52.jpg Edgar Link pending
img255116984_6.jpg Edgar Link pending
img255116984_7.jpg Edgar Link pending
img255116984_8.jpg Edgar Link pending
img255116984_9.jpg Edgar Link pending
kymr-20231231.htm Edgar Link pending
kymr-20231231.xsd Edgar Link pending
kymr-ex10_10.htm Edgar Link pending
kymr-ex10_12.htm Edgar Link pending
kymr-ex10_13.htm Edgar Link pending
kymr-ex10_16.htm Edgar Link pending
kymr-ex10_3.htm Edgar Link pending
kymr-ex21_1.htm Edgar Link pending
kymr-ex23_1.htm Edgar Link pending
kymr-ex31_1.htm Edgar Link pending
kymr-ex31_2.htm Edgar Link pending
kymr-ex32_1.htm Edgar Link pending
kymr-ex32_2.htm Edgar Link pending
kymr-ex97.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
kymr-20231231_htm.xml Edgar Link completed